Abstract
We describe a four-generation kindred with familial hypercholesterolemia (FH) in which two of the eight heterozygotes for a 5-kb deletion (exons 2 and 3) in the low density lipoprotein (LDL) receptor gene were found to have normal LDL-cholesterol levels. In our search for a gene responsible for the cholesterol-lowering effect in this family, we have studied variation in the genes encoding the LDL receptor, apolipoprotein (apo) B, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, apoAI-CIII-AIV, and lipoprotein lipase. The analysis showed that it was unlikely that variation in any of these genes was responsible for the cholesterol-lowering effect. Expression of the LDL receptor, as assessed in vitro with measurements of activity and mRNA levels, was similar in normo and hyperlipidemic subjects carrying the deletion. Analysis of the apo E isoforms revealed that most of the e2 allele carriers in this family, including the two normolipidemic 5-kb deletion carriers, were found to have LDL-cholesterol levels substantially lower than subjects with the other apo E isoforms. Thus, this kindred provides evidence for the existence of a gene or genes, including the apo e2 allele, with profound effects on LDL-cholesterol levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allain CC, Poon LS, Chan FCS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475
Basheeruddin K, Rechtoris C, Mazzone T (1993) Growth factors induce LDL receptor gene expression by modulating the binding of Sp1-like proteins. Circulation 88 [Suppl]:1–73
Bétard C, Kessling A, Roy M, Chamberland A, Lussier-Cacan S, Davignon J (1992) Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians. Hum Genet 88:529–536
Bhattacharya S, Wilson TME, Wojciechowski AP, Volpe CP, Scott J (1991) Hypervariable polymorphism in the APOC3 gene. Nucleic Acids Res 19:4799
Boerwinkle E, Xiong W, Fourest E, Chan L (1989) Rapid typing of tandemly repeated hypervariable loci by the PCR: application to the apoB 3′ hypervariable region. Proc Natl Acad Sci USA 86:212–216
Bouthillier D, Sing CF, Davignon J (1983) Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res 24:1060–1069
Breslow JL, Zannis VI, SanGiacomo TR, Third JLHC, Tracy T, Glueck CJ (1982) Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 23:1224–1235
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Dallongeville J, Davignon J, Lussier-Cacan S (1990) Relationship between plasma cholesterol levels and cholesterol esterification in isolated human mononuclear cells. Life Sci 47:2351–2357
Dallongeville J, Roy M, Leboeuf N, Xhignesse M, Davignon J, Lussier-Cacan S (1991) Apolipoprotein E polymorphism associated with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia. Arterioscler Thromb 11:272–278
Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21
Ferrières J, Sing CF, Roy M, Davignon J, Lussier-Cacan S (1994) Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia: sex-specific effects. Arterioscler Thromb 14:1553–1560
Fogelman AM, Elahi F, Sykes K, Van Lenten BJ, Territo MC, Berliner JA (1988) Modification of the Recalde method for the isolation of human monocytes. J Lipid Res 29:1243–1247
Goldstein JL, Brown MS (1989) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1215–1250
Goldstein JL, Basu SK, Brown MS (1983) Receptor-mediated endocytosis of LDL in cultured cells. Methods Enzymol 98:241–260
Hill JS, Hayden MR, Frohlich J, Pritchard PH (1991) Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb 11:290–297
Hobbs HH, Brown MS, Goldstein JL, Russell DW (1986) Deletion of exon encoding cysteine-rich repeat of LDL receptor alters its binding specificity in a subject with familial hypercholesterolemia. J Biol Chem 261:13114–13120
Hobbs HH, Leitersdorf E, Leffert CC, Cryer DR, Brown MS, Goldstein JL (1989) Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors. J Clin Invest 84:656–664
Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, Wang X (1993) SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 90:11603–11607
Kessling AM, Seed M, Taylor R, Wynn V, Humphries SE (1990) Rising cholesterol levels in children with familial hypercholesterolaemia. Biomed Pharmacother 44:373–379
Kotze MJ, De Villiers WJS, Steyn K, Kriek JA, Marais AD, Langenhoven E, Herbert JS, Graadt Van Roggen JF, Van der Westhuyzen DR, Coetzee GA (1993) Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations. Arterioscler Thromb 13:1460–1468
Kroon PA, Powell EE (1992) LDL receptor and HMG CoA reductase gene expression in human mononuclear cells parallels that in human liver and is coordinately regulated (abstract). Circulation 86 [Suppl I]: 1–548
Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH (1990) Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 85:1014–1023
Lipid Research Clinics Program (1974) Manual of laboratory operations, vol. 1. US Government Printing Office, Washington, DC
Lipid Research Clinics Program (1980) Population studies data book. NIH Publ no 80–1527, Washington, DC
Ma Y, Bétard C, Roy M, Davignon J, Kessling AM (1989) Identification of a second “French Canadian” LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet 36:219–228
Pieretti M, Zhang F, Fu Y. Warren ST, Oostra BA, Caskey CT. Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817–822
Powell EE, Kroon PA (1992) Measurement of mRNA by quantitative PCR with a nonradioactive label. J Lipid Res 33:609–614
Sampson EJ, Demers LM, Krieg AF (1975) Faster enzymatic procedure for serum triglycerides. Clin Chem 21:1983–1985
Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF (1994) Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb 14:1105–1113
Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268–285
Snyder SM, Terdiman JF, Caan B, Feingold KR, Hubl ST, Smith RS, Young SG (1993) Relationship of apolipoprotein E phenotypes to hypocholesterolemia. Am J Med 95:480–488
Sudhof TC, Goldstein JL, Brown MS, Russell DW (1985) The LDL receptor gene: a mosaic of exons shared with different proteins. Science 228:815–822
Wagner RD, Krul ES, Tang JJ, Parhofer KG, Garlock K, Talmud P, Schonfeld G (1991) ApoB-54. 8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the ApoB gene and hypobetalipoproteinemia. J Lipid Res 32:1001–1011
Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257:2518–2521
Wood S, Schertzer M, Hayden M, Ma Y (1993) Support for founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene. Hum Genet 91:312–316
Xhignesse M, Lussier-Cacan S, Sing C, Kessling AM, Davignon J (1991) Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 11:1100–1110
Yamakawa K, Takada K, Yanagi H, Tsuchiya S, Kawai K, Nakagawa S (1989) Three novel partial deletions of the low-density lipoprotein (LDL) receptor gene in familial hypercholesterolemia. Hum Genet 82:317–321
Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187–197
Zuliani G, Hobbs HH (1990) A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. Am J Hum Genet 46:963–969
Author information
Authors and Affiliations
Additional information
C. S. and M. G. contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sass, C., Giroux, LM., Ma, Y. et al. Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia. Hum Genet 96, 21–26 (1995). https://doi.org/10.1007/BF00214181
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00214181